FDA
-
-
-
-
-
-
-
Laidlaw Starts AEON Biopharma, Inc (AEON) at Buy
-
-
-
-
-
-
-
AEON Biopharma regains NYSE American listing compliance
-
-
-
-
-
-
-
AEON Biopharma Sets Annual Shareholder Meeting
-
-
-
-
-
-
-
AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program
-
-
-
-
-
-
-
AEON Biopharma signs debt exchange deal with Daewoong
-
-
-
-
-
-
-
AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
AEON Biopharma Announces CEO Transition
-
334,267 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


